
zzso zzso and zzso receptors on peripheral blood zzso zzso were zzso in 50 de zzso patients with idiopathic Parkinson's disease zzso in 36 zzso control subjects zzso zzso zzso zzso 16; essential zzso zzso zzso 10; other neurodegenerative diseases, zzso zzso 10), and in 26 healthy control subjects by zzso binding zzso techniques using zzso zzso and zzso as zzso Patients with zzso revealed a higher density zzso of zzso zzso zzso zzso and zzso zzso zzso receptors on zzso than either zzso or healthy control subjects, whereas no differences in zzso were observed among patients affected by other zzso diseases and healthy control zzso The affinity zzso of both zzso was similar in the groups zzso The zzso profile of zzso zzso and zzso binding was consistent with the labeling of zzso zzso and D3 zzso zzso zzso Twenty-five of the 50 patients with zzso were zzso after 3 months of therapy with zzso or zzso Both treatments reduced the density of zzso zzso zzso and zzso zzso zzso receptors on zzso to values comparable to those of control zzso The increased density of zzso and zzso receptors on zzso in de zzso zzso patients may represent an zzso mechanism resulting from the diffuse impairment of the zzso system in zzso 

